Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UK-5099 (PF-1005023) 是一种有效的线粒体丙酮酸转运蛋白(MPC) 抑制剂, 抑制丙酮酸依赖性 O2消耗的 IC50值为50 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 233 | 现货 | ||
2 mg | ¥ 329 | 现货 | ||
5 mg | ¥ 538 | 现货 | ||
10 mg | ¥ 828 | 现货 | ||
25 mg | ¥ 1,560 | 现货 | ||
50 mg | ¥ 2,590 | 待询 | ||
100 mg | ¥ 4,250 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 563 | 现货 |
产品描述 | UK-5099 (PF-1005023) is a specific and potent inhibitor of MPC carrier activity [1]. It potently inhibits pyruvate-dependent oxygen consumption by rat heart mitochondria (IC50: 50 nM) [1]. |
靶点活性 | MPC:50 nM |
体外活性 | The trypanosomal pyruvate carrier is found to be rather insensitive to inhibition by alpha-cyano-4-hydroxycinnamate (Ki: 17 mM) but can be completely blocked by UK-5099 (Ki: 49 μM)[2]. UK-5099 also inhibits the monocarboxylate transporter (MCT) [3]. UK5099 dose-dependently significantly inhibits the glucose-stimulated rise in oxygen consumption and at 150 μM reduced oxygen consumption below basal levels. UK5099 reduces ATP levels and increases ADP and AMP levels in 832/13 cells[4]. The UK5099 treated cells show a significantly higher proportion of side population fraction and express higher levels of stemness markers Oct3/4 and Nanog. The UK5099 application may be an ideal model for Warburg effect studies[5]. |
体内活性 | UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice[4]. |
细胞实验 | The 832/13 cell line derived from INS-1 rat insulinoma cells is used for experiments. Cell viability is measured using CellTiter Blue. The assay is based on the cellular reduction of resazurin to resorufin. The appearance of resorufin is monitored by fluorescence emission at 585 nm using a Spectramax M5 microplate reader with excitation at 555 nm. For UK5099-treated cells, cells are allowed to recover for 1 h before measuring cell viability. Data are expressed as -fold relative to no treatment or siCtrl[4]. |
动物实验 | C57BLK mice are fasted for 16 h prior to glucose challenge. UK5099 (32 μmol/kg of body weight) or DMSO in PBS is injected into the intraperitoneal cavity 30 min before injecting glucose (1.5 mg of glucose/g of body weight). Blood glucose levels are measured at 0, 10, 20, 30, 60, and 120 min after glucose injection[4]. |
别名 | UK 5099, PF-1005023, UK5099 |
分子量 | 288.3 |
分子式 | C18H12N2O2 |
CAS No. | 56396-35-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 28.8 mg/mL(100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.4686 mL | 17.343 mL | 34.6861 mL | 86.7152 mL |
5 mM | 0.6937 mL | 3.4686 mL | 6.9372 mL | 17.343 mL | |
10 mM | 0.3469 mL | 1.7343 mL | 3.4686 mL | 8.6715 mL | |
20 mM | 0.1734 mL | 0.8672 mL | 1.7343 mL | 4.3358 mL | |
50 mM | 0.0694 mL | 0.3469 mL | 0.6937 mL | 1.7343 mL | |
100 mM | 0.0347 mL | 0.1734 mL | 0.3469 mL | 0.8672 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
UK-5099 56396-35-1 Metabolism Others Mitochondrial Metabolism UK 5099 PF-1005023 inhibit PF 1005023 UK5099 Inhibitor PF1005023 inhibitor